The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matthew Barcus's Stock Ratings
Chardan Capital Analyst
Matthew Barcus is an analyst at Chardan Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/23/2025
Overall Average Return
18.0%
Smart Score
Overall Average Return Percentile
79th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/26/2025 | ZURA | Buy Now | Zura Bio | $1.50 | 566.67% | Matthew Barcus54% | $12 → $10 | Maintains | Buy | Get Alert |
| 11/08/2024 | ZURA | Buy Now | Zura Bio | $1.50 | 700% | Matthew Barcus54% | $14 → $12 | Maintains | Buy | Get Alert |
| 06/22/2023 | QURE | Buy Now | uniQure | $14.93 | 80.84% | Matthew Barcus54% | $45 → $27 | Maintains | Buy | Get Alert |
| 06/14/2023 | ZURA | Buy Now | Zura Bio | $1.50 | 833.33% | Matthew Barcus54% | → $14 | Initiates | → Buy | Get Alert |
| 05/30/2023 | XLO | Buy Now | Xilio Therapeutics | $0.83 | 738.93% | Matthew Barcus54% | → $7 | Reiterates | Buy → Buy | Get Alert |
| 05/23/2023 | IMVT | Buy Now | Immunovant | $14.50 | 120.69% | Matthew Barcus54% | $21 → $32 | Maintains | Buy | Get Alert |
| 05/17/2023 | PPBT | Buy Now | Purple Biotech | $2.76 | 298.55% | Matthew Barcus54% | → $220 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2023 | QURE | Buy Now | uniQure | $14.93 | 201.41% | Matthew Barcus54% | $56 → $45 | Maintains | Buy | Get Alert |
| 05/12/2023 | FIXX | Buy Now | Homology Medicines | — | — | Matthew Barcus54% | $144 → $126 | Maintains | Buy | Get Alert |
| 05/11/2023 | XLO | Buy Now | Xilio Therapeutics | $0.83 | 738.93% | Matthew Barcus54% | → $7 | Reiterates | → Buy | Get Alert |
| 04/18/2023 | ANIX | Buy Now | Anixa Biosciences | $2.90 | 210.34% | Matthew Barcus54% | → $9 | Reiterates | → Buy | Get Alert |
| 03/28/2023 | AMTI | Buy Now | Applied Molecular | — | — | Matthew Barcus54% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/22/2023 | ANIX | Buy Now | Anixa Biosciences | $2.90 | 210.34% | Matthew Barcus54% | $8 → $9 | Maintains | Buy | Get Alert |
| 03/17/2023 | IMNM | Buy Now | Immunome | $8.39 | -4.65% | Matthew Barcus54% | $9 → $8 | Maintains | Buy | Get Alert |
| 03/06/2023 | AMTI | Buy Now | Applied Molecular | — | — | Matthew Barcus54% | → $3 | Reiterates | → Buy | Get Alert |
| 02/28/2023 | QURE | Buy Now | uniQure | $14.93 | 301.88% | Matthew Barcus54% | → $60 | Reiterates | → Buy | Get Alert |
| 02/09/2023 | PPBT | Buy Now | Purple Biotech | $2.76 | 298.55% | Matthew Barcus54% | → $220 | Reiterates | → Buy | Get Alert |
| 02/06/2023 | IMVT | Buy Now | Immunovant | $14.50 | 44.83% | Matthew Barcus54% | $19 → $21 | Maintains | Buy | Get Alert |
| 12/23/2022 | ANIX | Buy Now | Anixa Biosciences | $2.90 | 175.86% | Matthew Barcus54% | → $8 | Initiates | → Buy | Get Alert |
| 12/21/2022 | XLO | Buy Now | Xilio Therapeutics | $0.83 | 738.93% | Matthew Barcus54% | → $7 | Initiates | → Buy | Get Alert |
| 12/02/2022 | AMTI | Buy Now | Applied Molecular | — | — | Matthew Barcus54% | → $3 | Initiates | → Buy | Get Alert |
| 12/01/2022 | ONCR | Buy Now | Oncorus | — | — | Matthew Barcus54% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/17/2022 | VINC | Buy Now | Vincerx Pharma | $0.06 | 4594.84% | Matthew Barcus54% | $80 → $60 | Maintains | Buy | Get Alert |
| 11/17/2022 | FIXX | Buy Now | Homology Medicines | — | — | Matthew Barcus54% | $180 → $144 | Maintains | Buy | Get Alert |
| 11/07/2022 | IMVT | Buy Now | Immunovant | $14.50 | 31.03% | Matthew Barcus54% | $12 → $19 | Maintains | Buy | Get Alert |
| 09/29/2022 | IMVT | Buy Now | Immunovant | $14.50 | -17.24% | Matthew Barcus54% | $14 → $12 | Maintains | Buy | Get Alert |
| 09/08/2022 | PPBT | Buy Now | Purple Biotech | $2.76 | 298.55% | Matthew Barcus54% | → $220 | Initiates | → Buy | Get Alert |
| 08/16/2022 | FIXX | Buy Now | Homology Medicines | — | — | Matthew Barcus54% | $252 → $180 | Maintains | Buy | Get Alert |
| 08/09/2022 | QURE | Buy Now | uniQure | $14.93 | 301.88% | Matthew Barcus54% | $65 → $60 | Maintains | Buy | Get Alert |
| 07/21/2022 | VBLT | Buy Now | Vascular Biogenics | — | — | Matthew Barcus54% | — | Downgrade | Buy → Neutral | Get Alert |
| 06/15/2022 | ONCR | Buy Now | Oncorus | — | — | Matthew Barcus54% | → $5 | Initiates | → Buy | Get Alert |
| 06/07/2022 | VINC | Buy Now | Vincerx Pharma | $0.06 | 6159.78% | Matthew Barcus54% | $220 → $80 | Maintains | Buy | Get Alert |
| 05/13/2022 | VINC | Buy Now | Vincerx Pharma | $0.06 | 17114.4% | Matthew Barcus54% | $280 → $220 | Maintains | Buy | Get Alert |
| 04/28/2022 | VBLT | Buy Now | Vascular Biogenics | — | — | Matthew Barcus54% | → $175 | Initiates | → Buy | Get Alert |
| 03/09/2018 | VBLT | Buy Now | Vascular Biogenics | — | — | Matthew Barcus54% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/21/2015 | VBLT | Buy Now | Vascular Biogenics | — | — | Matthew Barcus54% | → $875 | Initiates | → Buy | Get Alert |
